L Brands, a tale of two months

 

Moats trailed the broad US market in September, but not by much, as global markets recovered from a relatively weak August. 

For the Month Ending September 30, 2017

Performance overview

The Morningstar® Wide Moat Focus IndexTM ("Moat Index") trailed the S&P 500® Index slightly in September (3.04% vs 3.17 %).

Performance attribution

Financials and consumer discretionary stocks were the top contributors to MOAT Index performance in September. Victoria's Secret and Bath and Body Works operator L Brands, Inc. (L US, +14.88%) was the top performer in the Index, following two consecutive negative performing months. Financials firms T. Rowe Price Group, Inc. (TROW, +8.18%) and Wells Fargo & Co. (WFC US, +7.99%) were also strong performers for the month.

The worst performing MOAT Index constituent was Allergan PLC (AGN US, -10.69%). The drug manufacturer faced two setbacks in its development pipeline in September causing a selloff. Despite pipeline setbacks, Morningstar analysts believed Allergan represented an attractive value in a research note published on 25 September.

 

   

Important Disclosures

This commentary is not intended as a recommendation to buy or sell any of the named securities. Holdings will vary for MOAT and MOAT Index.

Issued by VanEck Investments Limited ABN 22 146 596 116 AFSL 416755 (‘VanEck’). VanEck is a wholly owned subsidiary of Van Eck Associates Corporation based in New York, United States. VanEck Vectors ETF Trust ARBN 604 339 808 (the ‘Trust’) is the issuer of shares in the VanEck Vectors Morningstar Wide Moat ETF (‘US Fund’). The Trust and the US Fund are regulated by US laws which differ from Australian laws. Trading in the US Fund’s shares on ASX will be settled by CHESS Depositary Interests (‘CDIs’) which are also issued by the Trust. The Trust is organised in the State of Delaware, US. Liability of investors is limited. VanEck Associates serves as the investment adviser to the US Fund. VanEck, on behalf of the Trust, is the authorised intermediary for the offering of CDIs over the US Fund’s shares and issuer in respect of the CDIs and corresponding Fund’s shares traded on ASX.

This information is general in nature and not financial advice. It does not take into account any person’s individual objectives, financial situation or needs. Before making an investment decision investors should read the product disclosure statement and with the assistance of a financial adviser consider if it is appropriate for their circumstances. A copy of the PDS is available atwww.vaneck.com.au or by calling 1300 68 38 37.

Investment in the US Fund may be subject to risks that include, among others, fluctuations in value due to market and economic conditions or factors relating to specific issuers. Medium capitalisation companies may be subject to elevated risks. The US Fund’s assets may be concentrated in a particular sector and may be subject to more risk than investments in a diverse group of sectors. The Morningstar® Wide Moat Focus Index™ was created and is maintained by Morningstar, Inc. Morningstar, Inc. does not sponsor, endorse, issue, sell, or promote the US Fund and bears no liability with respect to the US Fund or any security. Morningstar®, Morningstar Wide Moat Focus Index™ and Economic Moat™ are trademarks of Morningstar, Inc. and have been licensed for use by VanEck.


Published: 09 August 2018